Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 2Neoplasms 2Venous Thrombosis 1Pulmonary Embolism 1Embolism 1

Interventions

Dalteparin 3apixaban 2abelacimab 2MAA868 2isoquercitrin 1edoxaban 1calcium heparin 1bemiparin 1Tinzaparin 1Rivaroxaban 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Fondaparinux 1Enoxaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Venous Thrombosis × edoxaban × Clear all
NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡